(Circulation. 2000;101:1693.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
browski, MD, PhD
bieta Kramarz, MDFrom the Department of Noninvasive Cardiology, Central Clinical Hospital MMA, Warsaw, Poland.
Correspondence to Andrzej D
browski, ul. Foksal 12/14, m. 14, 00366 Warsaw, Poland.
| Abstract |
|---|
|
|
|---|
Methods and ResultsIn 148 patients with remote myocardial
infarction and premature ventricular beats on a routine
ECG, QT dispersion, defined as the difference between the maximum and
the minimum QT interval across the 12-lead ECG, was calculated
separately for the ventricular extrasystole and the
preceding sinus beat. In the total group of patients, QTd-V was greater
than QTd-S (83±33 versus 74±34 ms, respectively;
P=0.001). During a follow-up period of 35±17 months,
arrhythmic events (sustained ventricular
tachycardia, ventricular fibrillation, or
sudden death) were noted in 30 patients. A QTd-V of
100 ms was a
stronger univariate marker of arrhythmic events than was a
QTd-S of
100 ms, and multivariate analysis
selected only prolonged QTd-V (hazard ratio 3.81, 95% CI 2.2 to 11.2)
and low ejection fraction (hazard ratio 3.05, 95% CI 1.6 to 7.6) as
independent predictors of arrhythmic events.
ConclusionsThe magnitude of QTd-V was greater than that of QTd-S in the total group of patients. Prolonged QTd-V is associated with a significantly increased risk for arrhythmic events in postinfarction patients, and the prognostic significance of QTd-V exceeds that of QTd-S.
Key Words: electrocardiography intervals myocardial infarction risk factors
| Introduction |
|---|
|
|
|---|
To date, no information comparing QTd-V with QTd-S is available. Therefore, the present study was designed to assess the relation between these 2 variables and to compare the prognostic significance of QTd-V and QTd-S in postinfarction patients with premature ventricular beats on a routine ECG.
| Methods |
|---|
|
|
|---|
20 minutes, (2)
elevation in serum creatine kinase to at least twice the upper limit of
normal, and (3) typical ECG changes in a postadmission series of
ECGs. Thrombolytic therapy was received by 81 patients (55%) during the acute phase of myocardial infarction. Seventeen patients (11%) underwent delayed PTCA or CABG during their initial hospitalization. ß-Blocker treatment was administered to 108 (73%) patients, and angiotensin-converting enzyme inhibitors were administered to 31 (21%) patients at hospital discharge.
Patients treated with class I or III antiarrhythmic drugs at
presentation, patients with atrial fibrillation or flutter,
complete bundle branch block, or pacemaker rhythm, and patients
with unmeasurable QT intervals of sinus beats or
ventricular premature beats in >4 ECG leads were not
included in the study group. The clinical characteristics of 148
patients formed the study group of this report are summarized in Table 1
.
|
The indications for 24-hour ECG were to evaluate complaints (syncope, dizziness, palpitation, and angina) or the risk after myocardial infarction. Standard ECGs were recorded 1 to 12 months (5±2 months) after myocardial infarction as a routine examination before 24-hour ECG monitoring.
ECG Analysis
Simultaneous 12-lead ECGs were recorded at a
paper speed of 25 mm/s and were assessed at 4-fold enlargement for
accurate measurement of QT intervals by the same experienced observer
who was blinded to the clinical status of patients and follow-up
results.
The QT intervals were measured manually as premature ventricular beats and as the last preceding sinus beat; if the QRS complex of ventricular extrasystole merged with the T wave of the preceding sinus beat, the calculation was made on the earlier sinus beat. The end of the T wave was defined as a return to the isoelectric line. When a U wave interrupted the T wave, a tangent was drawn to the steepest descent of the T wave to the isoelectric line. Intersection of this tangent with the isoelectric line was considered as the end of the T wave. If the end of the T wave could not be reliably determined, measurements of the QT interval were not made, and these leads were excluded from the analysis. QT dispersion, defined as the difference between the maximum and the minimum QT intervals, was calculated separately for the ventricular extrasystole and preceding sinus beat. A minimum of 8 leads was required for QTd-V and QTd-S to be calculated. Intraobserver variability (between 2 measurements) and interobserver variability (between 2 observers) in the measurements of QT dispersion were calculated by using 30 randomly selected and duplicated ECGs; the average absolute difference between the 2 measurements was determined.
Follow-Up
Patients included in the study group were followed up after
inclusion and were contacted at 6-month intervals throughout the study
to determine their clinical status. Occurrence of documented sustained
ventricular tachycardia,
ventricular fibrillation, or sudden death was considered to
be an arrhythmic event. Sustained ventricular
tachycardia was defined as tachycardia of >100
bpm, lasting for
30 s or associated with hemodynamic
compromise. Patients were considered to have died suddenly if death
occurred within 1 hour after new or more serious symptoms. Also,
patients who died unexpectedly during sleep were considered to have
died suddenly. Adverse outcome represented by the
arrhythmic event was considered to be a complete observation. Surviving
patients were censored on the last day of known follow-up
status. Patients were also censored at the date of nonsudden
death.
Statistical Analysis
Continuous variables were expressed as mean±SD. Student
t test,
2 test, and linear
regression analyses were used where appropriate. Differences
were taken to be significant at P<0.05.
The univariate relation of arrhythmic events to
variables collected at the baseline examination was assessed by
log-rank test. In this analysis, dichotomized descriptors
(male; aged
60 years; time between myocardial infarction and start of
the follow-up <5 months; left ventricular ejection
fraction <40%; QTd-S
80,
90, and
100 ms; QTd-V
80,
90, and
100 ms; repetitive ventricular premature beats on
ambulatory ECG monitoring; prematurity index of ventricular
premature beats
1; and right bundle branch block configuration of
ventricular premature beats) were represented
as a value of 1 if present. In addition, the prognostic value of
QTd-V, which was divided into 3 categories (<80 ms,
80 and <100 ms,
and
100 ms), was assessed. Kaplan-Meier curves were used to
illustrate the difference in event-free survival between groups.
Cox proportional hazards analysis was applied to extract the independent covariates and to estimate their hazard ratios. Three models were examined by this procedure. In the first model, all variables with at least a trend toward prognostic significance (P<0.1) were entered. In the second model, QTd-S was excluded from the analysis, and in the third model, QTd-V was excluded from the analysis.
| Results |
|---|
|
|
|---|
In the total group of 148 patients, the mean QTd-V was 83±33 ms, and
the mean QTd-S was 74±34 ms (P=0.001). Compared with the
values of QTd-S, the values of QTd-V were higher in 92 (62%) of the
148 patients, lower in 46 (31%) of the patients, and identical in 10
(7%) of the patients. There was a weak but significant correlation
between measurements of QTd-V and QTd-S (Figure 1
). Similarly, in a subgroup of 43
patients for whom all 12 ECG leads were available for analysis
of QTd-V and QTd-S, the mean value of QTd-V was greater than mean value
of QTd-S (82±27 and 67±31 ms, respectively; P=0.018).
Correlation between the values of QTd-V and QTd-S was stronger in this
subgroup compared with the total group (r=0.37,
P=0.000).
|
Clinical Outcome
During a mean follow-up period of 35±17 months, 30 patients
(20%) met end-point events. Of these patients, 16 died suddenly, 13
had documented sustained ventricular
tachycardia, and 1 patient with ventricular
fibrillation was successfully resuscitated at the time of hospital
stay. Because of symptomatic complex premature
ventricular beats, treatment with antiarrhythmic drugs was
used during follow-up (before sudden death or the occurrence of
malignant ventricular tachycardia) in 7
patients (23%) in the group with subsequent arrhythmic events and in
21 patients (18%) in the group without subsequent arrhythmic events.
Sotalol was administered in 16 patients; amiodarone, in 7
patients; and other antiarrhythmic agents, in 5 patients. The treatment
with antiarrhythmic drugs during follow-up was guided by the results of
programmed ventricular stimulation in 6 patients and by the
results of ambulatory ECG monitoring in 22 patients.
Prognostic Value of QT Dispersion
QTd-V was significantly greater in the group of patients with
arrhythmic events than in the group without arrhythmic events (99±28
versus 79±34 ms, respectively; P=0.003). Similarly, QTd-S
was greater in patients with than in patients without arrhythmic events
during follow-up (94±37 versus 69±31 ms, respectively;
P=0.000).
The results of univariate analysis performed on 15
evaluated descriptors by use of the log-rank test are shown in
Table 2
. Values of sensitivity,
specificity, and positive and negative predictive accuracy calculated
according to a dichotomy point of 100 ms were as follows: 50%, 80%,
39%, and 86%, respectively, for QTd-S and 67%, 75%, 41%, and 90%,
respectively, for QTd-V. Among patients with QTd-V
100 ms, 41%
developed arrhythmic events compared with 10% of those with QTd-V
<100 ms; Figure 2
shows the Kaplan-Meier
event-free survival curves with QTd-V <80 ms, QTd-V
80 and <100 ms,
and QTd-V
100 ms.
|
|
The results of the Cox proportional hazards analyses of 3
models for predicting arrhythmic events are listed in Table 3
. Among variables analyzed in
the first model and in the second model, only 2 (increased QTd-V and
low left ventricular ejection fraction) were independent
predictors of arrhythmic events. When QTd-V
100 ms versus QTd-V <80
ms was used instead of QTd-V
100 ms versus QTd-V <100 ms in the
first model of the Cox procedure, the value of
2 increased from 31.84 to 33.28. Dispersion of
QTd-S reached the significant predictive value only in model 3, in
which QTd-V was not analyzed. Model 2 was better than model 3
in predicting arrhythmic events (
2=31.44
[P=0.000] versus
2=20.43
[P=0.000], respectively).
|
| Discussion |
|---|
|
|
|---|
Predictive Value of QT Dispersion
As in the total population of patients who survived a myocardial
infarction, the group of postinfarction patients with premature
ventricular beats on a standard ECG is not uniform, and
categories of patients with a higher and a lower risk also exist. The
identification of patients at increased risk of malignant
ventricular arrhythmias is problematic
and remains a major management goal. The data of the present study
show that measurement of QTd-V may be used for risk stratification in
postinfarction patients with premature ventricular beats on
a routine ECG. The results of the multivariate
analysis indicate that the prognostic significance of QTd-V
exceeds that of QTd-S. In predicting arrhythmic events, the sensitivity
and positive and negative predictive accuracy were higher for QTd-V
100 than for QTd-S. However, a high overlapping of the values for
QTd-V and QTd-S was observed between patients with and without
susceptibility to arrhythmic events, and the positive predictive
accuracy of both these measures in predicting arrhythmic events was
relatively low at all evaluated dichotomy points. Nevertheless, the
value of positive predictive accuracy of QTd-V and QTd-S exceeds that
obtained with the use of conventional noninvasive procedures. In the
study group of Farrell et al,9 low left
ventricular fraction, reduced heart rate variability, and
abnormal signal-averaged ECG had lower values of positive predictive
accuracy (10%, 17%, and 17%, respectively) in predicting arrhythmic
events after myocardial infarction. Higher values of positive
predictive accuracy of QTd-V and QTd-S in the present study may be
related to overrepresentation of patients with an increased
risk of arrhythmic events. Our study group consisted of patients with
premature ventricular beats assessed by a routine ECG. This
might lead to the selection of patients with an anatomic substrate for
malignant ventricular arrhythmias. This suggestion
is probable because the analysis of 24-hour ECG monitoring
revealed at least 1 episode of nonsustained ventricular
tachycardia in 41% of our patients, and the incidence of
arrhythmic events during follow-up was higher in the present study
than in other comparable studies.6 9
In contrast to the results of the present study, Zabel et al6 did not find an association between the occurrence of arrhythmic events in postinfarction patients and increased QTd-S. Zabel et al calculated QTd-S on ECGs that were recorded at hospital discharge, whereas in the present study, QTd-S was measured on ECGs obtained at least 1 month after myocardial infarction. Ventricular remodeling starts soon after myocardial infarction, but any infarct expansion may progress beyond the hospital stay. Remodeling of the infarcted left ventricle and the extent of the final myocardial damage determine the changes in QTd-S.10 This relation might explain why increased QTd-S measured earlier, at hospital discharge, was not a predictor of arrhythmic events in the study of Zabel et al.
Study Limitations
A limitation of the present study is that the sample size was
relatively small. This was partly due to the exclusion of patients
treated with antiarrhythmic drugs at presentation and of
patients who were not eligible for calculation of QTd-S. Standard ECGs
were recorded at 25 mm/s, but it was reported that
recording at 50 mm/s did not improve the accuracy of the
QT measurement because it resulted in obscuring the end of the T
wave.11
The duration of QT intervals was measured manually. At present, it has not been established that computerized measurements of QT dispersion are more accurate than manual measurements.12 Recently, Tran et al13 recommended a manual method for QT-interval measurements as a preferred procedure for QT dispersion studies.
In summary, our data demonstrate that in the total group of patients, QTd-V was greater than QTd-S. Prolonged QTd-V is associated with a significantly increased risk for arrhythmic events, and the prognostic significance of QTd-V exceeds that of QTd-S. Further studies comparing the prognostic implications of QTd-V and QTd-S are warranted to establish the real value of these variables in stratifying risk in patients after myocardial infarction.
Received July 19, 1999; revision received November 2, 1999; accepted November 8, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. Ueda, T. Hayashi, K. Tsumura, K. Yoshimaru, Y. Nakayama, and J. Yoshikawa Intravenous Nicorandil Can Reduce QT Dispersion and Prevent Bradyarrhythmia During Percutaneous Transluminal Coronary Angioplasty of the Right Coronary Artery Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2004; 9(3): 179 - 184. [Abstract] [PDF] |
||||
![]() |
D. S. Lee, L. D. Green, P. P. Liu, P. Dorian, D. M. Newman, F. C. Grant, J. V. Tu, and D. A. Alter Effectiveness of implantable defibrillators for preventing arrhythmic events and death: A Meta-Analysis J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1573 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Burnes, R. N. Ghanem, A. L. Waldo, and Y. Rudy Imaging Dispersion of Myocardial Repolarization, I: Comparison of Body-Surface and Epicardial Measures Circulation, September 11, 2001; 104(11): 1299 - 1305. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |